Glioma extracellular matrix molecules as therapeutic targets

Marzenna Wiranowska, Mumtaz V. Rojiani

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Scopus citations


Malignant gliomas which rarely metastasize, but are locally highly invasive into theextracellular matrix (ECM) microenvironment in the brain are difficult to treat. Despiteyears of research, current therapies including surgery, radiotherapy and chemotherapy areaimed at debulking of the brain tumor mass and targeting proliferating tumor cells. Thesetherapeutic approaches do not take into consideration the ECM, its composition and thechanges in ECM rigidity which can significantly affect glioma cell motility resulting intumor cell dissemination through the brain and establishment of new, distant tumor foci.Some ECM molecules such as metalloproteinases (MMPs) which are essential in matrixremodeling have been targeted therapeutically.However, due to the highly pleiotropic properties of MMPs, the outcomes of theclinical studies targeting these molecules have been disappointing and often resulted inincreased tumor growth. In addition, current therapies do not address the quiescentpopulation of the cancer stem cells which thrive in the ECM microenvironment of thevascular niche and are protected from therapeutic interventions. This chapter will focuson the review of the most recent information pertaining to the glioma extracellularmicroenvironment and identification of the possible biological targets within ECM foranti-glioma therapy.

Original languageEnglish (US)
Title of host publicationGliomas
Subtitle of host publicationSymptoms, Diagnosis and Treatment Options
PublisherNova Science Publishers, Inc.
Number of pages23
ISBN (Print)9781626180895
StatePublished - May 2013

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • General Medicine


Dive into the research topics of 'Glioma extracellular matrix molecules as therapeutic targets'. Together they form a unique fingerprint.

Cite this